Jiangsu Hengrui Pharmaceuticals Co.,Ltd (JNGHF)

OTCMKTS · Delayed Price · Currency is USD
7.75
+0.68 (9.62%)
Jun 15, 2026, 3:40 PM EST
Market Cap 47.27B
Revenue (ttm) 4.72B
Net Income (ttm) 1.18B
Shares Out n/a
EPS (ttm) 0.18
PE Ratio 40.15
Forward PE 32.54
Dividend 0.03 (0.38%)
Ex-Dividend Date Apr 29, 2026
Volume 100
Average Volume 1,025
Open 7.75
Previous Close 7.07
Day's Range 7.75 - 7.75
52-Week Range 7.07 - 8.87
Beta n/a
RSI n/a
Earnings Date Aug 20, 2026

About JNGHF

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China. [Read more]

Industry Pharmaceutical Preparations
Founded 1970
Employees 20,602
Stock Exchange OTCMKTS
Ticker Symbol JNGHF
Full Company Profile

Financial Performance

In 2025, JNGHF's revenue was 31.63 billion, an increase of 13.02% compared to the previous year's 27.98 billion. Earnings were 7.71 billion, an increase of 21.69%.

Financial numbers in CNY

News

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Quarterly report: Q1 2026

Jiangsu Hengrui Pharmaceuticals Co.,Ltd has published its Q1 2026 quarterly earnings report on April 22, 2026.

2 months ago - Filings

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Annual report: H2 2025

Jiangsu Hengrui Pharmaceuticals Co.,Ltd has published its H2 2025 annual report on March 25, 2026.

3 months ago - Filings

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Earnings release: H2 2025

Jiangsu Hengrui Pharmaceuticals Co.,Ltd released its H2 2025 earnings on March 25, 2026, summarizing the period's financial results.

3 months ago - Filings

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Quarterly report: Q3 2025

Jiangsu Hengrui Pharmaceuticals Co.,Ltd has published its Q3 2025 quarterly earnings report on October 27, 2025.

8 months ago - Filings

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Quarterly report: H1 2025

Jiangsu Hengrui Pharmaceuticals Co.,Ltd has published its H1 2025 quarterly earnings report on August 20, 2025.

11 months ago - Filings